Ivy functions within the telehealth and personalized care space, offering access to consultations and prescriptions for customized programs intended to support weight management goals, fitness needs, and longevity.
The platform claims to provide access to support without in-person visits, insurance requirements, or long approval timelines.
As part of its lineup and at the discretion of licensed healthcare providers, the platform could provide access to programs that may feature GLP-1, NAD+, peptides, and glutathione.
In this review, we examine the brand’s model and how it works, alongside its range of offerings, medical oversight process, and potential brand limitations.
Ivy operates on a digital-first model to connect you with licensed medical professionals, who may provide access to prescription-based programs focused on GLP-1 support, metabolic health, and cellular function.
The platform organizes its care model around a clear sequence that includes a free online quiz, evaluation by a board-certified and US-licensed healthcare provider, and direct shipment of medication to your specified address. Messaging with care providers takes place through the platform, allowing questions and follow-up communication throughout your program.
Across its weight-management and anti-aging categories, the platform provides access to prescription offerings, such as GLP-1, GLP-1 Microdose, MIC + B12, Metformin, NAD+, Sermorelin, Glutathione, and B12. Such offerings are presented as part of personalized plans rather than fixed programs, with eligibility determined during provider evaluation.
The brand claims that all compounded medications are prepared through partner pharmacies that comply with 503B and USP 797 standards. Quality and safety processes include potency verification within defined tolerances, sterility screening for bacteria and fungi, endotoxin testing aligned with USP 85 limits, and pH verification.
Ivy Rx’s Weight Management service centers on prescription GLP-1 options that are evaluated and prescribed at the discretion of licensed, U.S.-based medical providers.
The process begins with a short online health assessment that reviews medical history, lifestyle factors, and goals, followed by a provider evaluation to determine clinical appropriateness.
If approved, the platform may provide access to prescription offerings such as GLP-1, GLP-1 Microdose, along with MIC + B12, and Metformin. When deemed medically appropriate, the licensed providers may also provide prescriptions for brand-name medications such as Ozempic and Mounjaro.
GLP-1 receptor agonists such as Semaglutide work by mimicking the body’s natural glucagon-like peptide-1 hormone, which is responsible for regulating appetite, delaying gastric emptying, and improving insulin signaling. These effects may help decrease your daily caloric intake and suppress food cravings, potentially contributing to your fitness goals. Metformin primarily supports glucose regulation and insulin sensitivity, which might indirectly support metabolism and fat oxidation.
Across this segment, the platform emphasizes individualized care rather than uniform outcomes, noting that weight-management outcomes may vary based on biology, adherence, and lifestyle factors.
Ivy’s Longevity Care segment is structured to support energy metabolism, metabolic health, and delay age-related physiological changes through provider-guided prescription offerings. The longevity offerings available under this range, at the discretion of licensed providers, include NAD+, NAD+ nasal spray, Glutathione, B12, Sermorelin, and Metformin.
NAD+ could support cellular energy production, as the molecule plays a central role in supporting mitochondrial function and redox balance. Glutathione is a vital intracellular antioxidant involved in reducing oxidative stress and supporting natural liver detox pathways. Meanwhile, Sermorelin is a peptide that stimulates the body’s natural growth hormone release, which may influence tissue repair, body composition, and sleep-related recovery.
IvyRx presents its services through a single, centralized online care platform that connects assessment, clinical review, prescribing, fulfillment, and ongoing communication in one system. You start by completing a digital health questionnaire, which is reviewed by licensed healthcare providers directly within the platform. When appropriate, prescribing decisions are made inside the same interface, avoiding handoffs to external clinics or disconnected portals.
After approval, prescriptions are fulfilled through FDA-registered partner pharmacies and shipped directly to your specified address.
Order status and delivery updates are visible within the IvyRx account, while provider communication is handled through a built-in portal. This allows you to message clinicians, review guidance, and manage follow-ups without relying on phone calls or third-party tools.
The centralized structure aligns closely with the platform’s core offerings, including Weight Management and Longevity Care, which are positioned as ongoing care pathways rather than one-time transactions.
Programs such as GLP-1–based weight management benefit from consistent monitoring, refills, and periodic adjustments, while longevity-focused offerings like NAD+ protocols similarly depend on continued engagement and provider oversight.
IvyRx positions transparent pricing as a clear brand advantage by openly communicating costs and keeping them consistent across its care experience. Program prices are displayed directly on the website, allowing you to understand expected monthly expenses before starting an intake or clinical review.
For example, weight management programs such as personalized GLP-1 are listed with starting prices generally ranging from about $175 to $200 per month, while longevity-related programs such as NAD+ are shown at $200 per month. Other programs, including options like sermorelin or glutathione, are also presented with clearly stated monthly pricing. This upfront visibility helps you assess affordability without hidden steps or delayed disclosures.
The brand further supports transparency through flat and predictable pricing for certain programs. In the case of personalized GLP-1 care, the platform communicates that pricing remains the same across dosage levels, meaning you do not see automatic price increases as the program progresses.
IvyRx also avoids membership fees and mandatory add-ons. The listed price is positioned to reflect the core care program itself, rather than separating charges for provider review, prescribing, or fulfillment. As the platform operates on a cash-pay model and does not process insurance, prices remain consistent regardless of coverage status, simplifying billing and reducing variability. HSA and FSA payments are supported, and itemized invoices are provided so you can clearly see what you paid for and how charges are structured.
IvyRx’s service model is built around delivering core GLP-1 offerings with a streamlined structure rather than a broad ecosystem of supplementary services. The platform focuses primarily on prescription fulfillment for programs such as GLP-1–based weight management, NAD+ longevity programs, and peptides, including Sermorelin, with clinician review and basic educational support included as part of the standard process.
From a clinical services perspective, there is limited emphasis on optional add-ons beyond what is required for prescribing and safety. IvyRx does not prominently offer bundled lifestyle or health coaching, advanced metabolic or hormone testing packages, personalized nutrition programs, wearable device integration, or enhanced laboratory monitoring tiers. Ongoing support is generally provided through basic patient portal communication rather than through expanded care programs.
This simplified approach helps control costs and reduce complexity, but it also narrows personalization options. When looking for comprehensive programs that combine GLP-1 offerings with continuous coaching, detailed diagnostics, or integrated wellness tools, you may find fewer choices within IvyRx’s model.
Henry Meds operates as a U.S.-based telehealth platform built around ongoing, provider-supervised support for endocrine, metabolic, and sexual health needs, with a structure that emphasizes continuity rather than one-time prescribing.
The platform removes traditional insurance requirements and in-person clinic visits, instead relying on virtual consultations, secure messaging, and recurring subscriptions that include ongoing access to licensed providers.
Ivy also functions as a U.S.-based telehealth platform with a subscription model and no insurance requirement, but its positioning leans more heavily toward convenience, speed, and prescription access across weight management, longevity, and anti-aging categories.
While provider review is required, the platform presents itself as a streamlined entry point into ongoing GLP-1 programs, with a standardized three-step flow that prioritizes rapid onboarding and fast medication delivery.
Weight management is central to both platforms, but the scope and framing differ. Henry Meds focuses heavily on GLP-1–based weight management programs using compounded medications, such as injectable and oral Semaglutide, microdose Semaglutide options, oral Tirzepatide, liraglutide, and oral phentermine. The platform emphasizes individualized dosing, provider-led adjustments, and long-term metabolic management.
Meanwhile, Ivy’s weight management segment is narrower and more standardized, centering primarily on GLP-1, a microdose GLP-1 option, and additional options such as MIC + B12 and Metformin. Beyond its primary compounded offering, Ivy also offers a non-prescription GLP-1 Boost supplement.
Beyond weight management, Henry Meds also emphasizes hormone and sexual health. Women’s hormone replacement therapy, testosterone replacement therapy, and erectile dysfunction care are part of its offerings. TRT may be delivered through injections, topical creams, or oral formulations, depending on provider assessment, while erectile dysfunction care includes options such as Bimix, Trimix, and Quadmix. On the other hand, Ivy extends into longevity and anti-aging programs, offering access to options such as NAD+, Sermorelin, Glutathione, and B12.
Both platforms rely on compounded medications and clearly disclose regulatory limitations, but their disclosures are framed slightly differently. Henry Meds emphasizes that compounded medications are not FDA-approved and may differ from commercially available drugs in safety and efficacy, with medications sourced from U.S.-licensed 503(A) compounding pharmacies or 503(B) outsourcing facilities.
Ivy similarly discloses that compounded medications are not reviewed by the FDA, while placing additional emphasis on internal quality controls such as potency testing every three to six months, sterility testing, endotoxin screening under USP 85 limits, and pH verification.
Both platforms allow month-to-month cancellation, but Henry Meds more explicitly frames subscriptions as ongoing care relationships, while Ivy frames them as flexible access programs without long-term commitments.
AgelessRx functions as a U.S.-based telehealth platform centered on longevity, preventive medicine, and age-related health optimization.
The platform frames aging as a modifiable biological process and integrates prescription programs, diagnostics, and ongoing medical oversight into a single digital ecosystem. Support is delivered through licensed U.S. medical providers who review detailed online intakes and, when required by state regulations, conduct video consultations before approving programs.
Weight management represents a component of the platform’s broader strategy. The platform provides access to GLP-1, Microdosed GLP-1, alongside access to FDA-approved branded medications such as Ozempic®, Wegovy®, and Zepbound®.
AgelessRx also maintains a wide-ranging longevity-focused catalog, featuring offerings like Low Dose Naltrexone, Metformin, Rapamycin, NAD+, and Sermorelin. It also offers Glutathione support in injectable, transdermal patch, and nasal spray formats. Diagnostics and biomarker tracking further differentiate the platform, with biological age testing, metabolic panels, and phenotypic calculators, designed to support longitudinal tracking rather than diagnostic conclusions.
Ivy also operates as a U.S.-based telehealth platform without insurance requirements, but its positioning prioritizes speed, simplicity, and subscription-based access to defined programs across weight management care and longevity support. The model follows a standardized three-step flow built around a short online quiz, provider review, and rapid medication delivery that often occurs within two days.
Weight management forms a central structure of Ivy’s offering. The platform offers access to offerings such as GLP-1, MIC + B12, GLP-1 Microdose, and a non-prescription GLP-1 Boost formula. It also offers access to brand-name options like Mounjaro and Ozempic. Longevity and anti-aging support is delivered primarily through offerings, such as NAD+, Glutathione, Sermorelin, Metformin, and B12.
From a quality and compliance perspective, Ivy places strong emphasis on operational safeguards for compounded medications. Routine potency verification, sterility testing, endotoxin screening, and pH testing are highlighted as vital controls supporting safety and consistency.
While both operate within the same regulatory framework, AgelessRx emphasizes research alignment and longitudinal monitoring, whereas Ivyrx emphasizes convenience, simplicity, and rapid fulfillment.
To evaluate Ivy Rx, we looked at its operational history and presence across independent review forums, alongside how the brand handles customer disputes over time.
On the Better Business Bureau, the brand holds a C rating. The BBB ratings reflect a notable volume of service-related complaints, many of which center on delayed shipments, billing disputes, subscription cancellations, and dosage concerns.
Many users reported receiving incomplete or delayed medication shipments, inconsistent dosing information, repeated requests for documentation already submitted, and challenges in resolving issues despite ongoing payments. Some complaints also referenced subscription charges continuing after cancellation attempts, requiring escalation through BBB to achieve refunds or billing corrections.
Meanwhile, TenereTeam provides the brand with a more favorable 4.7 out of 5 score, although the score is based on a very limited number of reviews. This makes it difficult to consider to understand the brand’s overall customer experience.
From a brand credibility perspective, Ivy Rx presents itself as a HIPAA-compliant telehealth platform working with U.S.-licensed physicians and FDA-registered pharmacies. However, recurring themes included operational inconsistency, delayed communication, and billing friction.
In evaluating the brand, we analyzed its presence and verified user feedback shared on Trustpilot, where the brand currently maintains a 4.5 out of 5 rating, which is based on more than 3,000 reviews.
Many users described the sign-up process as quick and straightforward, often noting first-time discounts and smooth payment adjustments. Customer support agents are frequently named and praised for being patient, efficient, and thorough, with multiple users emphasizing that questions were resolved in a single interaction without the need for follow-ups. Speedy delivery, affordable pricing, and prompt handling of billing changes also appear repeatedly in the reviews.
However, a few users noted delays in receiving medications, incorrect dosages, or issues where prescriptions or preferences were not followed as selected. Some reviewers described gaps in communication between customer support, prescribing providers, and pharmacies, noting that medical messages sometimes went unanswered. Delays in order fulfillment and occasional shipment problems were also pointed out by a few users.
Our evaluation of the brand’s real user feedback indicates that many users viewed the platform’s services as efficient, approachable, and customer-friendly. However, negative experiences point to operational breakdowns that might negatively impact consumer trust.
Ivy Rx offers a structured pathway to access compounded options commonly associated with weight management and longevity.
The platform’s model prioritizes insurance-free access, remote evaluation, and convenience rather than in-person prescribing or pharmacy pickup. Provider oversight is part of the approval process, with licensed clinicians reviewing your submitted health information.
However, there are some considerations to keep in mind before opting for the platform’s services. The brand acknowledges that most medications it provides (such as GLP-1 and NAD+) are compounded and not FDA-approved in the same way as branded drugs. This means their safety, effectiveness, and manufacturing consistency are not reviewed through standard FDA approval pathways. Even with pharmacy compliance claims, variability in formulation remains a limitation. Compounded GLP-1 medications carry FDA black box warnings related to thyroid concerns and have been associated with pancreatitis, gallbladder disease, kidney injury, and severe gastrointestinal effects.
Factors like the availability of ongoing provider access, clarity around refill adjustments, and responsibility for monitoring side effects should also be considered before opting for the brand’s services.
Contact us at [email protected] or follow @leafsnap on Twitter! View our Privacy Policy.
